Worsening renal function in patients with acute heart failure undergoing aggressive diuresis is not associated with tubular injury

Circulation

Volumn 137, Issue 19, 2018, Pages 2016-2028

  Ahmad, Tariq ^a   Jackson, Keyanna ^a   Rao, Veena S ^a   Tang, W H Wilson ^b   Brisco Bacik, Meredith A ^c   Chen, Horng H ^d   Felker, G Michael ^e   Hernandez, Adrian F ^e   O’Connor, Christopher M ^f   Sabbisetti, Venkata S ^g   Bonventre, Joseph V ^g   Wilson, F Perry ^a   Coca, Steven G ^h   Testani, Jeffrey M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MAYO CLINIC   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f INOVA HEART AND VASCULAR INSTITUTE   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Acute kidney injury; Biomarkers; Heart failure; Renal insufficiency

Indexed keywords

BIOLOGICAL MARKER; CREATININE; CYSTATIN C; FUROSEMIDE; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACETYLGLUCOSAMINIDASE; CST3 PROTEIN, HUMAN; HAVCR1 PROTEIN, HUMAN; KIDNEY INJURY MOLECULE 1; LCN2 PROTEIN, HUMAN; LOOP DIURETIC AGENT;

ACUTE HEART FAILURE; AGED; ARTICLE; BODY WEIGHT; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DIURESIS; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART RATE; HOSPITALIZATION; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TUBULE DISORDER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY ANALYSIS; UREA NITROGEN BLOOD LEVEL; URINALYSIS; URINE VOLUME; WORSENING RENAL FUNCTION; ACUTE DISEASE; ACUTE KIDNEY FAILURE; BLOOD; CHEMICALLY INDUCED; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HEART FAILURE; KIDNEY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TIME FACTOR; TREATMENT OUTCOME; UNITED STATES; URINE; VERY ELDERLY;

ACETYLGLUCOSAMINIDASE; ACUTE DISEASE; ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; BIOMARKERS; CREATININE; CYSTATIN C; DIURESIS; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HEPATITIS A VIRUS CELLULAR RECEPTOR 1; HUMANS; KIDNEY; LIPOCALIN-2; MALE; MIDDLE AGED; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 85048304235     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.117.030112     Document Type: Article

References (35)

1. Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation. 2010;122:265–272. doi: 10.1161/CIRCULATIONAHA.109.933275.
2. Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O’Connor CM; NHLBI Heart Failure Clinical Research Network. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011;364:797–805. doi: 10.1056/NEJMoa1005419.
3. Bart BA, Goldsmith SR, Lee KL, Givertz MM, O’Connor CM, Bull DA, Redfield MM, Deswal A, Rouleau JL, LeWinter MM, Ofili EO, Stevenson LW, Semigran MJ, Felker GM, Chen HH, Hernandez AF, Anstrom KJ, McNulty SE, Velazquez EJ, Ibarra JC, Mascette AM, Braunwald E; Heart Failure Clinical Research Network. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med. 2012;367:2296–2304. doi: 10.1056/NEJMoa1210357.
4. Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, Bart BA, Bull DA, Stehlik J, LeWinter MM, Konstam MA, Huggins GS, Rouleau JL, O’Meara E, Tang WH, Starling RC, Butler J, Deswal A, Felker GM, O’Connor CM, Bonita RE, Margulies KB, Cappola TP, Ofili EO, Mann DL, Dávila-Román VG, McNulty SE, Borlaug BA, Velazquez EJ, Lee KL, Shah MR, Hernandez AF, Braunwald E, Redfield MM; NHLBI Heart Failure Clinical Research Network. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA. 2013;310:2533–2543. doi: 10.1001/jama.2013.282190.
5. Metra M, Davison B, Bettari L, Sun H, Edwards C, Lazzarini V, Piovanelli B, Carubelli V, Bugatti S, Lombardi C, Cotter G, Dei Cas L. Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail. 2012;5:54–62. doi: 10.1161/CIRCHEARTFAILURE.111.963413.
6. Forman DE, Butler J, Wang Y, Abraham WT, O’Connor CM, Gottlieb SS, Loh E, Massie BM, Rich MW, Stevenson LW, Young JB, Krumholz HM. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004;43:61–67.
7. Ather S, Bavishi C, McCauley MD, Dhaliwal A, Deswal A, Johnson S, Chan W, Aguilar D, Pritchett AM, Ramasubbu K, Wehrens XH, Bozkurt B. Worsening renal function is not associated with response to treatment in acute heart failure. Int J Cardiol. 2013;167:1912–1917. doi: 10.1016/j.ijcard.2012.05.004.
8. Barasch J, Zager R, Bonventre JV. Acute kidney injury: a problem of definition. Lancet. 2017;389:779–781. doi: 10.1016/S0140-6736(17)30543-3.
9. Guideline summary: KDIGO clinical practice guideline for acute kidney injury. National Guideline Clearinghouse (NGC). Rockville, MD: Agency for Healthcare Research and Quality; March 1, 2012. https://www.guideline.gov. Accessed January 12, 2018.
10. Brisco MA, Testani JM. Novel renal biomarkers to assess cardiorenal syndrome. Curr Heart Fail Rep. 2014;11:485–499. doi: 10.1007/s11897-014-0226-4.
11. Vaidya VS, Ozer JS, Dieterle F, Collings FB, Ramirez V, Troth S, Muniappa N, Thudium D, Gerhold D, Holder DJ, Bobadilla NA, Marrer E, Perentes E, Cordier A, Vonderscher J, Maurer G, Goering PL, Sistare FD, Bonventre JV. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol. 2010;28:478–485. doi: 10.1038/nbt.1623.
12. Vaidya VS, Ford GM, Waikar SS, Wang Y, Clement MB, Ramirez V, Glaab WE, Troth SP, Sistare FD, Prozialeck WC, Edwards JR, Bobadilla NA, Mefferd SC, Bonventre JV. A rapid urine test for early detection of kidney injury. Kidney Int. 2009;76:108–114. doi: 10.1038/ki.2009.96.
13. Park M, Hsu CY, Go AS, Feldman HI, Xie D, Zhang X, Mifflin T, Waikar SS, Sabbisetti VS, Bonventre JV, Coresh J, Nelson RG, Kimmel PL, Kusek JW, Rahman M, Schelling JR, Vasan RS, Liu KD; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators; CKD Biomarkers Consortium. Urine kidney injury biomarkers and risks of cardiovascular disease events and all-cause death: the CRIC study. Clin J Am Soc Nephrol. 2017;12:761–771. doi: 10.2215/CJN.08560816.
14. Bonventre JV. Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant. 2009;24:3265–3268. doi: 10.1093/ndt/gfp010.
15. Parikh CR, Moledina DG, Coca SG, Thiessen-Philbrook HR, Garg AX. Application of new acute kidney injury biomarkers in human randomized controlled trials. Kidney Int. 2016;89:1372–1379. doi: 10.1016/j.kint.2016.02.027.
16. Sasaki D, Yamada A, Umeno H, Kurihara H, Nakatsuji S, Fujihira S, Tsubota K, Ono M, Moriguchi A, Watanabe K, Seki J. Comparison of the course of biomarker changes and kidney injury in a rat model of drug-induced acute kidney injury. Biomarkers. 2011;16:553–566. doi: 10.3109/1354750X.2011.613123.
17. Emmens JE, Ter Maaten JM, Matsue Y, Metra M, O’Connor CM, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, Dittrich HC, Todd J, van Veldhuisen DJ, Hillege HL, Damman K, van der Meer P, Voors AA. Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome. Eur J Heart Fail. 2016;18:641–649. doi: 10.1002/ejhf.426.
18. Maisel AS, Wettersten N, van Veldhuisen DJ, Mueller C, Filippatos G, Nowak R, Hogan C, Kontos MC, Cannon CM, Müller GA, Birkhahn R, Clopton P, Taub P, Vilke GM, McDonald K, Mahon N, Nuñez J, Briguori C, Passino C, Murray PT. Neutrophil gelatinase-associated lipocalin for acute kidney injury during acute heart failure hospitalizations: the AKINESIS study. J Am Coll Cardiol. 2016;68:1420–1431. doi: 10.1016/j.jacc.2016.06.055.
19. Sokolski M, Zymliński R, Biegus J, Siwołowski P, Nawrocka-Millward S, Todd J, Yerramilli MR, Estis J, Jankowska EA, Banasiak W, Ponikowski P. Urinary levels of novel kidney biomarkers and risk of true worsening renal function and mortality in patients with acute heart failure. Eur J Heart Fail. 2017;19:760–767. doi: 10.1002/ejhf.746.
20. Legrand M, De Berardinis B, Gaggin HK, Magrini L, Belcher A, Zancla B, Femia A, Simon M, Motiwala S, Sambhare R, Di Somma S, Mebazaa A, Vaidya VS, Januzzi JL Jr; Global Research on Acute Conditions Team (GREAT). Evidence of uncoupling between renal dysfunction and injury in cardiorenal syndrome: insights from the BIONICS study. PLoS One. 2014;9:e112313. doi: 10.1371/journal.pone.0112313.
21. Verbrugge FH, Dupont M, Shao Z, Shrestha K, Singh D, Finucan M, Mullens W, Tang WH. Novel urinary biomarkers in detecting acute kidney injury, persistent renal impairment, and all-cause mortality following decongestive therapy in acute decompensated heart failure. J Card Fail. 2013;19:621–628. doi: 10.1016/j.cardfail.2013.07.004.
22. Hanberg JS, Tang WHW, Wilson FP, Coca SG, Ahmad T, Brisco MA, Testani JM. An exploratory analysis of the competing effects of aggressive decongestion and high-dose loop diuretic therapy in the DOSE trial. Int J Cardiol. 2017;241:277–282. doi: 10.1016/j.ijcard.2017.03.114.
23. Coady SA, Mensah GA, Wagner EL, Goldfarb ME, Hitchcock DM, Giffen CA. Use of the National Heart, Lung, and Blood Institute Data Repository. N Engl J Med. 2017;376:1849–1858. doi: 10.1056/NEJMsa1603542.
24. McWilliam SJ, Antoine DJ, Sabbisetti V, Pearce RE, Jorgensen AL, Lin Y, Leeder JS, Bonventre JV, Smyth RL, Pirmohamed M. Reference intervals for urinary renal injury biomarkers KIM-1 and NGAL in healthy children. Biomark Med. 2014;8:1189–1197. doi: 10.2217/bmm.14.36.
25. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–612.
26. Testani JM, McCauley BD, Chen J, Shumski M, Shannon RP. Worsening renal function defined as an absolute increase in serum creatinine is a biased metric for the study of cardio-renal interactions. Cardiology. 2010;116:206–212. doi: 10.1159/000316038.
27. Testani JM, Brisco-Bacik MA. Worsening renal function and mortality in heart failure: causality or confounding? Circ Heart Fail. 2017;10;e003835.
28. Felker GM, O’Connor CM, Braunwald E; Heart Failure Clinical Research Network Investigators. Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil? Circ Heart Fail. 2009;2:56–62. doi: 10.1161/CIRCHEARTFAILURE.108.821785.
29. Testani JM, Kimmel SE, Dries DL, Coca SG. Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction. Circ Heart Fail. 2011;4:685–691. doi: 10.1161/CIRCHEARTFAILURE.111.963256.
30. Testani JM, Brisco MA, Chen J, McCauley BD, Parikh CR, Tang WH. Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion. J Am Coll Cardiol. 2013;62:516–524. doi: 10.1016/j.jacc.2013.05.027.
31. Metra M, Nodari S, Parrinello G, Bordonali T, Bugatti S, Danesi R, Fontanella B, Lombardi C, Milani P, Verzura G, Cotter G, Dittrich H, Massie BM, Dei Cas L. Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail. 2008;10:188–195. doi: 10.1016/j.ejheart.2008.01.011.
32. Testani JM, Damman K, Brisco MA, Chen S, Laur O, Kula AJ, Tang WH, Parikh C. A combined-biomarker approach to clinical phenotyping renal dysfunction in heart failure. J Card Fail. 2014;20:912–919. doi: 10.1016/j.cardfail.2014.08.008.
33. Kula AJ, Hanberg JS, Wilson FP, Brisco MA, Bellumkonda L, Jacoby D, Coca SG, Parikh CR, Tang WHW, Testani JM. Influence of titration of neurohormonal antagonists and blood pressure reduction on renal function and decongestion in decompensated heart failure. Circ Heart Fail. 2016;9:e002333. doi: 10.1161/CIRCHEARTFAILURE.115.002333.
34. Testani JM, McCauley BD, Chen J, Coca SG, Cappola TP, Kimmel SE. Clinical characteristics and outcomes of patients with improvement in renal function during the treatment of decompensated heart failure. J Card Fail. 2011;17:993–1000. doi: 10.1016/j.cardfail.2011.08.009.
35. Xu K, Rosenstiel P, Paragas N, Hinze C, Gao X, Huai Shen T, Werth M, Forster C, Deng R, Bruck E, Boles RW, Tornato A, Gopal T, Jones M, Konig J, Stauber J, D’Agati V, Erdjument-Bromage H, Saggi S, Wagener G, Schmidt-Ott KM, Tatonetti N, Tempst P, Oliver JA, Guarnieri P, Barasch J. Unique transcriptional programs identify subtypes of AKI. J Am Soc Nephrol. 2017;28:1729–1740. doi: 10.1681/ASN.2016090974.